Hong Kong targets biomedicine powerhouse status in debut five-year plan
Biomedicine is set to feature in Hong Kongโs first five-year plan, due to be unveiled next week, as the cityโs top officials signal closer medical cooperation across the Greater Bay Area. Lending weight to those ambitions, global pharmaceutical company GSK emphasised its interest in expanding its role in the regionโs biotech development on Wednesday, at the fifth Hong Kong International Biotechnology Conference and Exhibition (BIOHK). Speaking at the event, Hong Kong Secretary for Health Lo...